What are invisible assets?

Invisible assets are valuable attributes that are not tangible, which means that the naked eye cannot be touched or seen. This term is most often associated with trade, but can also apply to individuals. Two of the most common invisible assets include the reputation and recognition of a name or brand. The advantages of some types of invisible assets can be measured and are often included in the balance sheet. They may include asset patents and development and research. Persons with these types of assets often are easier to gain time and maintain employment, ensure loans and gain positions in communities. These types of assets are particularly useful for those looking for leadership, especially in politics. Many national and local leaders have been able to develop their political career based on these types of activ. Some political engineers claim that it is almost impossible to have a career in politics without these assets. It is generally assumed that most people consider the longevity of society to be a value with whichIT value of the company, and the quality of the goods, services or product they represent. This is one of the reasons why start -up businesses can have difficult time to compete with established businesses.

Reputation may be associated with the recognition of names when defining the invisible assets of the company. So they do so often do companies that have survived in a few years of business because they work very hard to create a good reputation. Some factors that play an important role in the reputation are customer service, relins weaken and fair business practices.

patents, research and development are generally considered invisible assets, because even if they can be measured or calculated, it is often almost impossible to determine their impact on profitability in the long run. In many cases, their value may not be obvious for many months or years. One examples of intangible assets that include research, development and patents is pharmaceuticalKá Society investigating a new medicine. The new medicine does not have to be available to the public for several months after it has been developed and patented, but it would still be an asset for society, even if it would not create any income yet.